Structural and Functional Analysis of the GADD34:PP1 eIF2α Phosphatase  by Choy, Meng S. et al.
ReportStructural and Functional Analysis of the
GADD34:PP1 eIF2a PhosphataseGraphical AbstractHighlightsd Distinct domains in GADD34 are utilized to scaffold PP1 and
eIF2a
d GADD34 is an intrinsically disordered protein that binds PP1
via RVxF and F/F motifs
d PEST repeats in GADD34 represent an independent site for
eIF2a bindingChoy et al., 2015, Cell Reports 11, 1885–1891
June 30, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.05.043Authors
Meng S. Choy, Permeen Yusoff,
Irene C. Lee, ..., Rebecca Page,






Attenuation of protein synthesis following
eIF2a phosphorylation promotes survival
of cells experiencing environmental and
metabolic stress. Choy et al. use
structural, biochemical, and cell
biological approaches to show that the
stress-induced protein GADD34
independently recruits PP1 and eIF2a for
eIF2a dephosphorylation, to restore





Structural and Functional Analysis
of the GADD34:PP1 eIF2a Phosphatase
Meng S. Choy,1 Permeen Yusoff,2 Irene C. Lee,3 Jocelyn C. Newton,4 Catherine W. Goh,3 Rebecca Page,4
Shirish Shenolikar,2,3,* and Wolfgang Peti1,5,*
1Department of Molecular Pharmacology, Physiology and Biotechnology, Brown University, Providence, RI 02912, USA
2Signature Research Program in Cardiovascular and Metabolic Disorders, Duke-NUS Graduate Medical School, Singapore 169857,
Singapore
3Signature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Graduate Medical School, Singapore 169857,
Singapore
4Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA
5Department of Chemistry, Brown University, Providence, RI 02912, USA
*Correspondence: shirish.shenolikar@duke-nus.edu.sg (S.S.), wolfgang_peti@brown.edu (W.P.)
http://dx.doi.org/10.1016/j.celrep.2015.05.043
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
SUMMARY
The attenuation of protein synthesis via the phos-
phorylation of eIF2a is a major stress response of
all eukaryotic cells. The growth-arrest- and DNA-
damage-induced transcript 34 (GADD34) bound to
the serine/threonine protein phosphatase 1 (PP1) is
the necessary eIF2a phosphatase complex that re-
turns mammalian cells to normal protein synthesis
following stress. The molecular basis by which
GADD34 recruits PP1 and its substrate eIF2a are not
fully understood, hindering our understanding of the
remarkable selectivity of the GADD34:PP1 phospha-
tase for eIF2a. Here, we report detailed structural
and functional analyses of the GADD34:PP1 holoen-
zyme and its recruitment of eIF2a. The data highlight
independent interactions of PP1 and eIF2a with
GADD34, demonstrating that GADD34 functions as a
scaffold both in vitro and in cells. This work greatly
enhances our molecular understanding of a major
cellular eIF2a phosphatase and establishes the foun-
dation for future translational work.
INTRODUCTION
Protein synthesis in eukaryotes is actively controlled via the
reversible phosphorylation of numerous translation initiation
and elongation factors. In this context, the phosphorylation of
the a-subunit of eIF2 (eukaryotic Initiation Factor 2), a trimeric
complex composed a, b, and g subunits, is a pivotal downregu-
lator of translation initiation following changes in the cellular envi-
ronment or stress (Walton and Gill, 1976). Under non-stressed
conditions, eIF2a is largely unphosphorylated. In the presence
of GTP, the eIF2 complex recruits Met-tRNA and ribosomal sub-
units to the translation start site to initiate mRNA translation.
However, stresses, such as nutrient deprivation, heat shock,
among other factors, activate one or more of four protein
kinases, namely, GCN2, PERK, PKR, and HRI to phosphorylate
eIF2a on a single serine, temporarily repressing general protein
synthesis (Harding et al., 2000).
However, some mRNAs are preferentially translated following
eIF2a phosphorylation. These include mRNAs encoding the tran-
scription factors, ATF4 and CHOP, which together induce the
stress response gene that encodes growth-arrest- and DNA-
damage-induced transcript 34 (GADD34; protein phosphatase 1
regulatory subunit 15A, PPP1R15A). As the stress declines, the
GADD34 protein, by recruiting the ser/thr protein phosphatase 1
(PP1), facilitates the dephosphorylation of phospho-eIF2a,
restoring normal protein synthesis (Connor et al., 2001; Novoa
et al., 2001). The structural basis bywhich theGADD34:PP1 com-
plex functions as an eIF2a phosphatase remains unclear.
GADD34 (674 residues, 73.5 kDa) possesses ER-targeting
helix, four central PEST repeats and a C-terminal PP1-binding
domain (Figure 1A). Bioinformatics analyses suggest that
GADD34 is largely unstructured (Figure S1), making it impossible
to assign function(s) simply by analysis of its primary structure.
Phylogenetic analyses point to the existence of GADD34-like
proteins in many multicellular organisms, from Caenorhabditis
elegans to humans (Ceulemans et al., 2002). While some lower
eukaryotes, like Drosophila, possess a single gene encoding
dGADD34, mammals possess two genes encoding GADD34
and CReP (PPP1R15B) that share sequence homology solely
in the C-terminal PP1-binding domain (Chen et al., 2015; Jousse
et al., 2003). Finally, viral infection often results in PKR-mediated
eIF2a phosphorylation, which inhibits protein synthesis and viral
replication in the infected host cells. However, the genomes of
selected poxviruses encode polypeptides, like ICP34.5 (also
known as g34.5), with sequence homology to the PP1-binding
domain of GADD34 (He et al., 1997). By recruiting PP1,
ICP34.5 promotes eIF2a dephosphorylation allowing these
viruses to evade this host cell surveillancemechanism. Together,
these data argued that the approximately 100 amino acids en-
compassing the conserved PP1-binding domain among distinct
eIF2a phosphatases contain the critical determinants that direct
eIF2a dephosphorylation.
Recent discoveries of small molecular inhibitors, namely, Sa-
lubrinal (Boyce et al., 2005) and Guanabenz (Tsaytler et al.,
2011), which target eIF2a phosphatases showed that they
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protected cells from cytotoxic cell death resulting from protein
misfolding and aggregation (known as proteotoxicity). Indeed
both compounds improved symptoms and prolonged life in
animal models of human neurodegenerative diseases (Jiang
et al., 2014; Saxena et al., 2009). Interestingly, Salubrinal in-
hibited the mammalian GADD34 and CReP-containing eIF2a
phosphatases as well as the ICP34.5-containing viral phospha-
tase. By contrast, Guanabenz showed greater selectivity for
the GADD34-containing eIF2a phosphatases. On the other
hand, Guanabenz prevented prion protein aggregation and
toxicity in both yeast and mammalian cells (Tribouillard-Tanvier
et al., 2008). This is particularly remarkable as Saccharomyces
cerevisiae does not express a GADD34 ortholog. Instead, the
yeast eIF2g subunit contains an N-terminal extension containing
a PP1-binding RVxF motif that directly recruits PP1 (Glc7p) and
catalyzes eIF2a dephosphorylation (Rojas et al., 2014). Thus,
there is an urgent need for a better understanding of the structure
of mammalian eIF2a phosphatases and the mode of action of in-
hibitors to facilitate the future development of therapies against
human diseases associated with proteotoxicity.
Here, we utilized nuclear magnetic resonance (NMR) spec-
troscopy, X-ray crystallography, biochemistry, and cell biology
to elucidate how GADD34 binds PP1 and recruits its substrate,
eIF2a. The crystal structure of the GADD34:PP1 holoenzyme
(the complex between PP1 and the PP1-binding domain of
GADD34) shows that GADD34 uses both the RVxF and FF mo-
tifs to bind PP1. We also show that the selectivity for eIF2a as a
substrate is greatly enhanced by its binding to one or more of the
central PEST domains in GADD34. The data establish that
GADD34 functions as a scaffold, utilizing distinct domains to re-
cruit PP1 and eIF2a in vitro and in living cells. Together, this work
significantly advances our understanding of a protein phospha-
tase complex that is present at high levels in stressed or
diseased cells but not detected in healthy cells, providing unique
opportunities for future drug development.
RESULTS
The GADD34 PP1-Binding Domain Is Intrinsically
Disordered
Previous studies identified the RVxF (555KVRF558) motif that is
required for PP1 binding in the C-terminal domain of GADD34
(Brush et al., 2003) (Figure 1A). To examine the interaction of
GADD34 with PP1, we expressed GADD34513–631, a construct
previously used in the analysis of the interaction of GADD34
with PP1 (Brush et al., 2003). Our studies showed that
GADD34513–631 is heat stable (80
C, 15 min; Figure S1) and
that its 2D [1H,15N] HSQC spectrum lacked chemical shift disper-
sion in the 1HN dimension, confirming that the GADD34 PP1-
binding domain is an intrinsically disordered protein (IDP).
Given that approximately one-third of the N-terminal 38 resi-
dues in GADD34513–631 are prolines, and there was no experi-
mental evidence that GADD34 residues 513–551 contribute to
PP1-binding, we compared the 2D [1H,15N] HSQC spectrum of
GADD34513–631 with that of GADD34552–621. The 2D [
1H,15N]
HSQC spectra of the two GADD34 polypeptides overlapped
well but the quality of the data for GADD34552–621 was sig-
nificantly better. Thus, we used GADD34552–621 for detailed
NMR analysis. We achieved an 95% sequence-specific back-
bone assignment (four prolines, Figure 1B). Secondary structure
propensity (SSP) analysis (Marsh et al., 2006) showed two
regions with preferred helical secondary structure (helix a1,
582WEQLARDRS590, 40% populated; helix a2, 610AARARA
WARLRN621,70% populated; Figure 1C). Consistently, helices
a1 and a2 also showed reduced fast timescale motions in heter-
onuclear [15N]-NOE experiments (hetNOE), while the region sur-
rounding the RVxF site was highly dynamic (Figure 1D). Preferred
secondary structure elements often contribute to protein:protein
interactions. Thus, we used X-ray crystallography to determine
the three-dimensional structure of theGADD34:PP1 holoenzyme
to evaluate the roles of helices a1 and a2 in PP1 binding and to
reveal whether and how this region of GADD34 dictates sub-
strate selection by bound PP1.
Crystal Structure of GADD34:PP1 Holoenzyme
GADD34552–621:PP1 (GADD34552–621 was used in NMR studies)
did not produce crystals. Additional GADD34 peptides (e.g.,
GADD34552–602; GADD34552–591; constructs based on the NMR
analysis) were also screened for crystal formation, ultimately
yielding crystals for GADD34552–602:PP1 and GADD34552–591:
PP1, allowing for complete structure determination of the
GADD34552–591:PP1 complex (Table S1; 2.29 A˚). Clear electron
density was observed for 16 GADD34 residues with the
sequence 553ARKVRFSEKVTVHFLA568 (Figures 2A and 2B).
The complex buried 1,500 A˚2 of solvent accessible surface
area. To ensure that GADD34552–591 was not proteolytically
cleaved during crystallization, 20 GADD34552–591:PP1 crystals
were washed and subjected to SDS-PAGE. The molecular
size, determined by the migration of the free GADD34552–591
Figure 1. The GADD34 PP1-Binding Domain Is Intrinsically Disor-
dered
(A) GADD34 domain structure; ER localization domain, PEST domain (four
PEST repeats; labeled 1–4; each40 aa) and a PP1-binding domain (includes
canonical PP1-binding motif RVxF [KVRF]). GADD34241–674, GADD34513–631,
and GADD34552–621 are constructs used.
(B) Annotated 2D [1H,15N] HSQC of GADD34552–621. The narrow
1HN chemical
shift dispersion is a hallmark of IDPs.
(C) Secondary Structure Propensity (SSP) analysis of GADD34552–621 reveals
two preferred a-helical secondary structures (helices a1 and a2).
(D) Helices a1 and a2 have also reduced fast timescale motions.
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(Figure 2C), confirmed that GADD34552–591 was not degraded.
Activity of the GADD34:PP1 holoenzyme was confirmed by the
dephosphorylation of a model substrate, p-nitro-phenyl phos-
phate (pNPP) (Figure S2).
Isothermal titration calorimetry (ITC) of PP1a7–330 and
GADD34552–567 confirmed a one-to-one binding ratio with a Kd
of 62 ± 14 nM (Figure 2D). The Kd of GADD34552–567 for PP1
was 6.5-fold weaker than that determined for some PP1 regu-
lators, namely, PNUTS and spinophilin (Choy et al., 2014; Ra-
gusa et al., 2010) (8.7 and 9.3 nM, respectively), but close to
that for NIPP1 (Kd of 73 nM) (O’Connell et al., 2012). Competitive
fluorescence anisotropy experiments with a longer GADD34
construct confirmed that GADD34552–567 constitutes the com-
plete PP1 binding domain (Figure S2).
The GADD34:PP1 Holoenzyme
GADD34 binds PP1 via two recognized PP1-binding motifs
(Bollen et al., 2010; Choy et al., 2014). First, the residues Val556
and Phe558, which constitute the RVxF motif in GADD34, bind
the hydrophobic RVxF-binding pocket on the surface of PP1
(Figure 2B). Substituting Val556 and Phe558 with alanines results
in complete loss of GADD34 binding by PP1 (Brush et al.,
2003). Recently, we identified an RVxF motif ‘‘lid’’ residue
(Leu407 in PNUTS; Leu437 in spinophilin) that further stabilizes
the RVxF interaction (Choy et al., 2014). However, as also
observed for PP1 regulator NIPP1, no lid residue is present in
GADD34 (Figure S2). Second, GADD34 binds PP1 via the FF
motif, a motif recently identified in several PP1 regulators,
including spinophilin (Ragusa et al., 2010), NIPP1 (O’Connell
et al., 2012) and PNUTS (Choy et al., 2014). The FF motif of
GADD34 is formed by Val564 and His565, where His565 in
GADD34 forms a p-stacking interaction with Tyr78 in PP1
(Choy et al., 2014) (Figure 2B). Interestingly, the partially popu-
lated GADD34 helices a1 and a2 do not contribute to the direct
interaction with PP1; instead, they likely allow for the recruitment
of additional proteins to GADD34 (Brush et al., 2003).
As previously shown, PP1 interaction motifs in regulatory pro-
teins can contribute to PP1 binding and/or PP1 regulation (Choy
et al., 2014; O’Connell et al., 2012; Ragusa et al., 2010). So far,
both the RVxF and FFmotifs have been ascribed roles primarily
in PP1 binding (Choy et al., 2014). Indeed, phosphatase assays
using the GADD34:PP1-specific substrate, eIF2a, showed that
the complex readily dephosphorylated phosho-eIF2a (phos-
phorylated by PKR). Similar levels of dephosphorylation were
observed regardless of the GADD34 peptide (GADD34513–631
or GADD34552–591) used for holoenzyme formation suggesting
that residues adjacent to the GADD34 PP1-interaction domain
do not contribute to the activity of this heterodimeric complex
(Figure S2). However, this does not preclude the possibility
that association of eIF2a with other regions of GADD34 restrict
the substrate specificity and/or enhance the activity of
GADD34-associated phosphatase.
GADD34 Recruitment of the Substrate eIF2a Is
Mediated by the GADD34 PEST Domain
The GADD34:PP1 holoenzyme structure suggested that resi-
dues outside the minimal GADD34 PP1 binding domain recruit
eIF2a. To test whether PP1 is required for eIF2a recruitment by
GADD34, we performed immunoprecipitation experiments (IP)
using flag-tagged full-length GADD34 (WT and a PP1-binding
deficient variant where the GADD34 555KVRF558 motif was
mutated to KARA). eIF2a was sedimented to the same extent
by both WT and KARA GADD34 (Figure 3A), confirming that
the eIF2a association with GADD34 is independent of PP1
binding.
Then, we used NMR spectroscopy to test for a direct interac-
tion between the GADD34 PP1-binding domain and eIF2a.
NMR-active 15N-labeled eIF2a4–184 (N-terminal domain) was
produced and tested for chemical shift perturbations (CSPs)
following the addition of unlabeled GADD34513–631. CSPs could
result from direct interaction between the two proteins or from
changes in the conformation of eIF2a resulting from eIF2a:
GADD34 interactions. No CSPs were detected suggesting
that the GADD34 PP1-binding domain does not bind eIF2a
(Figure S3).
To identify the GADD34 domain(s) that mediates eIF2a
recruitment, we analyzed eIF2a binding to a GADD34 poly-
peptide that includes both the PEST repeats and the PP1-bind-
ing domain (His-GADD34241–674) and then compared it to a
GADD34 polypeptide that includes only the PP1-binding domain
(His-GADD34513–631). Only GADD34241–674 sedimented eIF2a
from HEK293T cell lysates, establishing that GADD34 resi-
dues 241–513 are required for stable eIF2a recruitment (Fig-
ure 3B). Additional deletion analyses established that a peptide
Figure 2. The Structure of the GADD34:PP1 Holoenzyme
(A) GADD34 (residues 553–568, light blue, electron density 2Fo-Fc contoured
at 1s) and PP1a7–300 (gray, surface) form a complex. Two Mn
2+ ions (pink
spheres) are bound at the PP1 active site; bound phosphate is shown
as sticks. No electron density was observed for GADD34 residues 552 or
569–591.
(B) GADD34 PP1-binding domain with the two primary interaction sites (RVxF
and FF residues are shown as sticks) highlighted.
(C) SDS-PAGE of 20 GADD34552–591:PP1a7–300 crystals; comparable
migration of GADD34 from crystals and control (GADD34552–591 alone)
shows that no proteolytic degradation of GADD34552–591 occurred during
crystallization.
(D) ITC of GADD34552–567 and PP1a7–330.
Data were recorded in triplicate.
Cell Reports 11, 1885–1891, June 30, 2015 ª2015 The Authors 1887
encompassing only the PEST repeats (GADD34241–513) bound
eIF2a, with the PEST repeats 1, 2, and 3 (GADD34323–463) being
prominent contributors to eIF2a recruitment (Figure 3C).
GADD34 Recruits Both PP1 and eIF2a
To study the association of GADD34 with both PP1 and eIF2a in
cells, we used a bimolecular fluorescence complementation
(BiFC) assay (Hu et al., 2002). Here, PP1a and eIF2a, each fused
to distinct non-fluorescent halves of Yellow Fluorescent Protein
(YFP), were transfected in COS-7 cells and the cells analyzed
for the reconstitution of YFP fluorescence using confocal micro-
scopy. When WT GADD34 was co-transfected in COS-7 cells
containing the N-YFP-PP1 and C-YFP-eIF2a, YFP fluorescence
was greatly enhanced, indicating the formation of the heterotri-
meric complex compared to cells not expressing GADD34 (vec-
tor control) or cells expressing another PP1 regulator, neurabin-
1, which binds PP1 but not eIF2a (Figure 4A). As anticipated,
BiFC fluorescence was localized primarily at the ER, similar to
that seen for GFP-GADD34 (Figure 4B). A similar experiment,
performed with the PP1-binding deficient variant of GADD34
(KARA), showed little or no YFP signal establishing that both
eIF2a and PP1 must be recruited to GADD34 to reconstitute
YFP fluorescence. These studies demonstrated that GADD34
functions as a protein scaffold to bring PP1 in proximity to its
substrate, eIF2a (Figures 4C and S4).
DISCUSSION
Mammals possess two eIF2a phosphatases. The CReP:PP1 ho-
loenzyme is constitutively expressed and likely controls basal
eIF2a dephosphorylation to ensure continued protein synthesis
in the absence of stress. However, under conditions of stress,
increased phosphorylation of eIF2a results in significant repres-
sion of general protein synthesis allowing cells to conserve or
redirect their energy sources to overcome the stress. The
GADD34 mRNA is one of a handful of genes actively translated
in the presence of phospho-eIF2a and functions in a feedback
loop to restore general protein synthesis and promote cell re-
covery from stress. Gene disruption studies suggested that
inhibiting the CReP:PP1 complex may be associated with
toxicity as CReP-null mice are smaller and do not thrive after
birth (Harding et al., 2009). By contrast, the GADD34:PP1 com-
plex is only present in stressed or diseased cells and GADD34-
null mice are largely normal (Harding et al., 2009; Kojima et al.,
2003; Patterson et al., 2006). Thus, the major focus of drug dis-
covery programs targeting eIF2a phosphatases to protect cells
from protein misfolding disorders is to selectively target the
GADD34:PP1 complex. However, structural information on the
Figure 4. Bimolecular Fluorescence Complementation Assays
Highlight the Role of GADD34 as a Scaffolding Protein
(A) Flag-tagged GADD34 enhances the BiFC signal that results from the
complementation of N-YFP-PP1a and C-YFP-eIF2a to YFP. Overexpression
of neurabin-1, a neuronal PP1 regulatory protein (negative control), does not
assemble the BiFC complex.
(B) Localization of GFP-tagged GADD34 and neurabin-1 (COS-7 cell over-
expression).
(C) Model: GADD34 domain structure and the proposed PP1a and eIF2a
binding sites (PP1 and eIF2a structures are shown).Figure 3. Recruitment of eIF2a Is Mediated by the GADD34 PEST
Domain
(A) Immunoprecipitation (IP) experiment using WT- and KARA-GADD34.
GADD34 recruits eIF2a from the HEK293T cell lysate independent of PP1
binding.
(B) IP experiment using His6-GADD34241–674 and His6-GADD34513–631. Only
His6-GADD34241–674 binds eIF2a (HEK293T cells lysate), while both His6-
GADD34241–674 and GADD34513–631 bind PP1.
(C) FLAG vector or FLAG-GADD34 proteins were expressed in HEK293 cells
and IP using anti-FLAG-conjugated to agarose beads. The IP and whole-cell
lysates (WCLs) were subjected to immunoblotting (IB) with indicated anti-
bodies. Molecular weight markers (kDa) are shown.
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GADD34:PP1 complex that might guide the development of
GADD34-specific drugs has been lacking.
Our work shows that GADD34 has little 3D structure and
belongs to the family of IDPs (Figure 1). This might, in part,
explain the short half-life of the GADD34 protein in the cells,
where it is degraded by the proteasome with a half-life of %
1 hr. Common with many PP1 regulators, which also show disor-
dered structure particularly within the PP1-binding domain,
GADD34 readily and specifically interacts with PP1 to form a
functional phosphatase holoenzyme (Figure 2). To do this,
GADD34 uses two well-established PP1-anchoring motifs:
the canonical RVxF motif found in R85% of PP1 regulators
as well as the FF motif, a newly identified motif predicted to
be present in 20% of PP1 regulators (Choy et al., 2014; Peti
et al., 2013) (Figure 2). Although these motifs provide for tight
binding of PP1 by GADD34 they do not account for the
unique specificity of the GADD34:PP1 complex as an eIF2a
phosphatase.
Here, we showed that GADD34 interacts with its substrate
eIF2a via one or more of the central PEST repeats (Figure 3).
Earlier studies established that the PEST sequences not only
drive protein turnover, but also mediate the association with reg-
ulatory proteins (Molinari et al., 1995). In that context, our earlier
studies showed that PEST repeats in GADD34 did not determine
the stability of the GADD34 protein in cells (Brush and Shenoli-
kar, 2008), leading us to hypothesize that they represented
sites of protein-protein interactions. Our cellular experiments in
particular highlighted the necessity for GADD34-mediated scaf-
folding of both PP1 and eIF2a for efficient and selective de-
phosphorylation of phospho-eIF2a. The central PEST domain
includes three repeats of 15 hydrophobic and charged amino
acids followed by long stretches of negatively charged poly-
Glu and Asp residues. Notably, this domain is only present in
GADD34; it is not present in CReP or the viral protein, ICP34.5,
which share homology with GADD34 only in the PP1-binding
domain. Yet, CReP and ICP34.5 can form active eIF2a phospha-
tases. Moreover, BiFC studies of ICP34.5 demonstrated the abil-
ity of the viral protein to recruit both PP1 and eIF2a and reconsti-
tute YFP fluorescence (Li et al., 2011) albeit less efficiently than
the fluorescence signal obtained with GADD34 in the current
studies. Nevertheless, these studies hinted at a potential
eIF2a-binding site within the PP1-binding domain of ICP34.5.
However, our cellular and biochemical studies showed that the
isolated PP1-binding domain, GADD34513–674, was unable to re-
cruit eIF2a as effectively asWTGADD34 and identified the PEST
domain as the primary, high-affinity eIF2a-docking site in
GADD34. We speculate that while the PP1-binding domain of
GADD34 together with PP1 may bind eIF2a transiently to allow
for eIF2a dephosphorylation, the evolution of the additional
eIF2a association domain uniquely present in GADD34 may pro-
vide for more efficient reversal of the much higher levels of phos-
pho-eIF2a seen in stressed cells. Indeed, earlier studies that
compared a truncated GADD34 containing the central PEST re-
peats and the C-terminal PP1-binding domain suggested that
this polypeptide generated a more active eIF2a phosphatase
than the full-length GADD34 (Novoa et al., 2001), indicating the
presence of both positive and negative structural elements that
dictate the activity of GADD34-containing eIF2a phosphatase.
In recent years, there has been an increased interest in the
development of small molecule inhibitors of the GADD34:PP1
holoenzyme, exploiting the cytoprotective effects of attenuating
global protein synthesis in diseased cells and tissues experi-
encing chronic protein misfolding. These efforts have yielded
two structurally unrelated compounds, Salubrinal (Boyce et al.,
2005) and Guanabenz (Tsaytler et al., 2011). Unlike compounds
that target the active site of PP1 and consequently modulate the
covalent modifications on a large number of cellular phospho-
proteins, the narrower specificity of Salubrinal and Guanabenz
to selectively alter cellular eIF2a phosphorylation was inter-
preted as arising from their ability to dissociate the GADD34:PP1
complex (Boyce et al., 2005; Tsaytler et al., 2011). Indeed, the
disruption of GADD34:PP1 was noted in the presence of milli-
molar concentrations of Guanabenz. Due to our ability to recon-
stitute a purifiedGADD34:PP1 holoenzyme in vitro, we examined
the ability of both Guanabenz and Salubrinal to dissociate the
GADD34:PP1 complex. No discernable dissociation of the com-
plex was observed. Quite the contrary, high micromolar concen-
trations of Salubrinal may even enhance the interaction of
GADD34 with PP1 (Figure S4). Furthermore, we performed crys-
tal trials of the GADD34:PP1 complex in the presence of 5 mM
Guanabenz but obtained no evidence for the disruption of the
GADD34:PP1 holoenzyme by this drug; i.e., the GADD34:PP1
holoenzyme was intact, and no electron density for Guanabenz
was identified. Similarly, we have obtained no direct evidence
for impaired PP1 or eIF2a binding by GADD34 in the presence
of either Guanabenz or Salubrinal. Taken together, these data
highlight the need for more work aimed at defining the mode of
action of these drugs. The availability of structural information
on the key contact points required to assemble GADD34:PP1
complex may also yield new strategies for the identification of
small molecules that selectively disrupt this eIF2a phosphatase
complex and provide a new avenue for drug development.
EXPERIMENTAL PROCEDURES
In brief proteins were expressed in E. coli BL21 (DE3) or BL21-CodonPlus
(DE3)-RIPL competent cells (Agilent). Purification of PP1 was performed as
previously described (Choy et al., 2014). GADD34 was purified using heat pu-
rification (80C, 15 min).
Crystallization of the GADD34:PP1 Holoenzyme
Crystals of GADD34552–591:PP1a7–300 holoenzyme were grown using sitting
drop (200 nl) vapor diffusion in 0.2 M ammonium phosphate dibasic, 20%
w/v polyethylene glycol 3350. X-ray data to 2.29 A˚ were collected at
the beamline 12.2 Stanford Synchrotron Radiation Lightsource (SSRL) at
100 K and a wavelength of 0.98 A˚ using a Pilatus 6M PAD detector. The
GADD34552–591:PP1a7–300 structure was solved by molecular replacement us-
ing Phaser as implemented in Phenix, using PP17–300 (PDBID: 3E7A) as the
search model (Kelker et al., 2009). A solution was obtained in space group
P212121; clear electron density for the bound GADD34 was visible in the initial
maps. The initial models of the GADD34552–591:PP1a7–300 were built using Phe-
nix.AutoBuild, followed by iterative rounds of refinement in PHENIX and
manual building using Coot.
NMR Spectroscopy
NMR measurements were performed at 298 K on a Bruker Avance 500 MHz
spectrometer with a HCN TCI z-gradient cryoprobe. The NMR spectra
were processed and analyzed using Topspin 3.1 (Bruker) and CARA soft-
ware package (http://www.cara.nmr.ch). The hetNOE measurement and
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secondary structure propensity calculation were performed as previously
described.
BiFC Assay
For BiFC assays, plasmid DNAs encode the yellow fluorescence protein (YFP)
pair (YN-PP1a and YC-eIF2a), together with the scaffolding proteins GADD34
and neurabin-1 were transfected into 60%–70% confluence COS-7 cells
grown in glass bottom Lab-Tek Chamber Slide (Nunc) using FuGENE 6. A
vector control (Cyan Fluorescence Protein [CFP]) was used to evaluate the
transfection efficiency, and also to normalize and quantify the BiFC signal.
To minimize non-specific BiFC signal, lower plasmid concentrations were
used (250 ng for the BiFC pairs and scaffolding protein; 50 ng for the CFP vec-
tor control). Transfected cells were grown overnight in a 37C incubator with
5% CO2. Two hours before imaging, cells were transferred to an incubator
pre-set at 30C for the maturation of the complemented YFP. The live cell im-
ages were captured using Nikon confocal microscope with motorized stage
with environment chamber for temperature control and CO2 delivery. Image
analysis was performed using MetaMorph (Molecular Devices).
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